Baxter
BAX
#1210
Rank
โ‚ฌ14.41 B
Marketcap
28,22ย โ‚ฌ
Share price
0.75%
Change (1 day)
-19.78%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ12.56 Billion

According to Baxter's latest financial reports the company's total debt is โ‚ฌ12.56 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Baxter - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ12.99 B-18.98%
2022-12-31โ‚ฌ16.03 B-0.81%
2021-12-31โ‚ฌ16.16 B192.27%
2020-12-31โ‚ฌ5.53 B3.96%
2019-12-31โ‚ฌ5.32 B74.68%
2018-12-31โ‚ฌ3.04 B4.08%
2017-12-31โ‚ฌ2.92 B10.67%
2016-12-31โ‚ฌ2.64 B-55.56%
2015-12-31โ‚ฌ5.95 B-19.84%
2014-12-31โ‚ฌ7.42 B11.85%
2013-12-31โ‚ฌ6.63 B48.05%
2012-12-31โ‚ฌ4.48 B12.07%
2011-12-31โ‚ฌ4.00 B21.29%
2010-12-31โ‚ฌ3.29 B13.84%
2009-12-31โ‚ฌ2.89 B7.84%
2008-12-31โ‚ฌ2.68 B27%
2007-12-31โ‚ฌ2.11 B-0.34%
2006-12-31โ‚ฌ2.12 B-24.67%
2005-12-31โ‚ฌ2.81 B-10.98%
2004-12-31โ‚ฌ3.16 B-12.87%
2003-12-31โ‚ฌ3.63 B-18.27%
2002-12-31โ‚ฌ4.44 B46.11%
2001-12-31โ‚ฌ3.04 B21.45%
2000-12-31โ‚ฌ2.50 B-11.73%
1999-12-31โ‚ฌ2.83 B0.03%
1998-12-31โ‚ฌ2.83 B21.16%
1997-12-31โ‚ฌ2.34 B36.16%
1996-12-31โ‚ฌ1.71 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ4.91 B-60.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.74 B 17.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.71 B-14.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.14 B 52.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.43 B-88.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ33.62 B 167.64%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.06 B-83.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ26.97 B 114.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ1.57 B-87.43%๐Ÿ‡บ๐Ÿ‡ธ USA